Table 3.
The demographic and clinical features of 12 NMO/NMOSD patients after treatment.
| NMO/NMOSD patients with PR | NMO/NMOSD patients with NR | |
|---|---|---|
| n | 6 | 6 |
| Age (years) | 47.5 (25–56) | 56 (53–63) |
| Female/male | 5/1 | 6/0 |
| CSF WBC count (106/L) | 19 (5–91) | 28 (4–58) |
| CSF protein (g/L) | 0.82 (0.45–1.21) | 0.745 (0.52–2.7) |
| CSF IgG (mg/L) | 96 (25.3–176) | 88.45 (31.9–181) |
Data shown are medians and ranges, except as specified. CR: complete remission; CSF: cerebrospinal fluid; PR: partial remission; WBC: white blood cell. Normal values: CSF WBC count, 0–8 × 106/L; CSF protein concentration, 0.15–0.45 g/L; CSF IgG concentration, 0–34 mg/L.